The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4%
, /PRNewswire/ -- The topical drug delivery market is projected to reach by 2025 from in 2020, at a CAGR of 6.4% during the forecast period. The growth of this market is majorly driven by the high prevalence of skin and soft tissue infections, the increasing prevalence of eye diseases, and burns. However, the presence of alternative drug delivery modes such as oral and injectable routes is expected to restrain the growth of this market during the forecast period.Read the full report: Based on product, the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products.The semi-solid formulations segment accounted for the larger market share in 2019.The easy application of semi-solid formulations, and their ability to deliver a wide variety of drug molecules is resulting in a stable demand for this segment among end users.Based on route of administration, the topical drug delivery market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal, vaginal drug delivery, and nasal drug delivery.The dermal drug delivery segment is expected to witness the highest growth during the forecast period.This is mainly due to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance. Besides, dermal products have fewer regulatory requirements than ophthalmic products, where sterility testing is mandatory.The home care settings segment accounted for the largest share of the market in 2019.This is attributed to the factors such as the convenience and affordability of topical drugs for home administration.Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. In this regard, technological advancements have helped patients undergo therapies effectively and safely at home.The topical drug delivery market in the is estimated to grow at the highest CAGR during the forecast period. This is due to high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, all of which are driving adoption of topical drug delivery in the .• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%• By Designation – C-level–43%, Director-level–32%, Others–25%• By Region – North America–38%, Europe–29%, Asia Pacific–23%, RoW- 10%The key players operating in the topical drug delivery market include Johnson & Johnson (US), Nestlé SA (), Novartis AG (), GlaxoSmithKline (UK), Bausch Health Companies (), Merck & Co (US), Bayer AG (), Hisamitsu Pharmaceutical (), Glenmark Pharmaceuticals (), Cipla Ltd (), Crescita Therapeutics Inc. (), Mylan (US), Encore Dermatology, Inc. (US), LEO Pharma (), Almirall, S.A (), Aclaris Therapeutics, Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Teligent Pharma (US), Perrigo Pharma (US), Allergan (), Biofrontera, Inc. (US), Crown Laboratories Inc. (US), Akorn Inc. (US), Ingenus Pharmaceuticals (US), and Sun Pharmaceuticals ().The report analyzes the topical drug delivery market and aims at estimating the market size and future growth potential of this market based on various segments such as product, route of administration, facility of use, and region.The report also includes a product portfolio matrix of various topical drug delivery products available in the market.The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global topical drug delivery market. The report analyzes this market by product, route of administration, and facility of use• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global topical drug delivery market• Market Development: Comprehensive information on the lucrative emerging markets by product, route of administration, and facility of use• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global topical drug delivery market• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global topical drug delivery market.Read the full report: About ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001
PR Newswire - PRF · 10/07 11:50